Edition:
United States

Anuron Kumar Mitra

FDA approves Pulmonx's valve to treat lung disease

Jun 29 2018

The U.S. Food and Drug Administration on Friday approved Pulmonx Inc's valve to treat a severe form of obstructive lung disease, most often characterized by shortness of breath.

Array BioPharma gets FDA nod for melanoma combo treatment

Jun 27 2018

The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.

Cardinal Health misses profit on Cordis woes, shares fall

May 03 2018

Cardinal Health Inc's quarterly profit missed analysts' expectations as inventory and cost issues hurt its Cordis medical device unit, and the U.S. drug distributor said it saw prices of generic drugs fall more than expected.

AmerisourceBergen sees Memphis plant back on track by 2019; shares rise

May 02 2018

Drug distributor AmerisourceBergen Corp posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent.

LabCorp's Covance business powers quarterly profit beat; shares rise

Apr 25 2018

Laboratory Corp of America Holdings posted a quarterly profit on Wednesday that beat analysts' estimates, helped by higher demand at the unit performing clinical trials for drugmakers, and prompting the company to raise its full-year revenue target.

Regeneron CEO says fears over Eylea 'greatly exaggerated'

Feb 08 2018

Fears of the demise of blockbuster eye drug Eylea were "greatly exaggerated," Regeneron Pharmaceuticals Inc's chief executive said on Thursday, after the treatment and new eczema drug Dupixent powered the company's fourth-quarter results.

AmerisourceBergen gets U.S. subpoena regarding Memphis plant

Feb 06 2018

AmerisourceBergen Corp on Tuesday said it received a grand jury subpoena from U.S. prosecutors seeking documents related to laboratory testing procedures at a facility that produces around half of the compounded drugs it supplies.

McKesson says drug prices competitive but not volatile like 2017

Feb 01 2018

U.S. drug wholesaler McKesson Corp said prices of generic drugs were still competitive, but not as volatile as in 2017 when prices fell sharply, which should help the company as it benefits from a major tie-up with Walmart.

Dialysis provider DaVita swings to loss on impairment charge

Nov 07 2017

DaVita Inc , the biggest U.S. dialysis services provider, swung to a third-quarter loss due to an impairment charge it took for the continued underperformance of its Medical Group healthcare delivery and management unit.

AmerisourceBergen expects tumbling generic drug prices to settle

Nov 02 2017

AmerisourceBergen Corp said it expects stubbornly low generic drug prices, which have plagued drugmakers and wholesalers, to not deteriorate further next year, and brushed off concerns about Amazon's possible entry into the industry.

World News